3,5-Aryl, heteroaryl or cycloalkyl substituted-1,2,4-oxadiazoles as s1p receptor agonists
                        
                            
                                申请人:Doherty A. George
                            
                            
                                公开号:US20070043014A1
                            
                            
                                公开(公告)日:2007-02-22
                            
                            The present invention encompasses compounds of Formula I: (I) as well as the pharmaceutically acceptable salts thereof. The compounds are useful for treating immune mediated diseases and conditions, such as bone marrow, organ and tissue transplant rejection. Pharmaceutical compositions and methods of use are included.
                            本发明涵盖化合物I式:(I),以及其药学上可接受的盐。该化合物对于治疗免疫介导的疾病和病况,如骨髓、器官和组织移植排斥等非常有用。药物组合物和使用方法也包括在内。